– On track to announce topline data in Q1 2025 – – Virtual KOL event scheduled on October 30th to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program for lorundrostat in hypertension – RADNOR, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other prevalent cardiovascular diseases driven by dysr ...

- Target Hospitality Board Disbands Special Committee -- Target Hospitality to Reinvigorate Focus on Allocating Capital to High Return Initiatives, Including In-Organic Growth -- Reaffirms 2024 Outlook Given Strength of Year-to-Date Operating Results -THE WOODLANDS, Texas, Sept. 25, 2024 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality," "Target" or the "Company") (Nasdaq: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality s ...

Key TakeawaysLevi Strauss posted a stylized image resembling Beyonce's "Cowboy Carter" album cover on Instagram that may hint at a collaboration with the superstar.Levi's CEO Michelle Gass reportedly pushed back the company's goal of reaching $9 billion to $10 billion in annual revenue by 2027.The company earlier this year reported $6.2 billion in revenue for its fiscal 2023. Levi Strauss & Co. (LEVI) hinted that a collaboration with superstar Beyonce may be on the horizon in an Instagram post on Monday. Th ...

Retailers are preparing for the holiday season with as much enthusiasm as shoppers looking for great deals. The season, which accounts for a sizable chunk of yearly revenues, is a make-or-break for retailers. To make the most of the festive season and win over early-bird shoppers, Target Corporation (TGT) is back with impressive deals and expanded product offerings.Target Circle Week: The Holiday KickoffTarget kicks off the holiday festivities with Target Circle Week, running from Oct. 6-12. This week-long ...

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute MyocarditisSeptember 24, 2024 7:27 AM EDT | Source: Cardiol Therapeutics Inc.Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it has achieved their target patient enrollment in the VIRAGE Phase 2b cl ...

My recommendation for MYT Netherlands Parent (NYSE: MYTE ) is a buy rating. I am positive that the strategy MYTE has employed will help it drive growth to a low 20% over the medium term. Notably, the flywheel effect that MYTEI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-t ...

I recently joined The REIT Forum and if you are looking for more investment ideas like this one, get them exclusively at The REIT Forum with access to our subscriber only portfolios.With comparable sales turning positive in Q2 FY24 after four consecutive quarters of decline and operating margins steadily rising, Target (NYSE: TGT ) is showing improving trends in its fundamentals with strength inAmrita runs a boutique family office fund in beautiful Vancouver, where she leads the investment strategy for the ...

文章核心观点 - 该文章介绍了一名资深研究分析师Roberts Berzins的背景和经验 [1] - 他在金融管理领域拥有10年以上的从业经验,曾帮助多家顶级企业制定财务策略并执行大规模融资 [1] - 他还致力于在拉脱维亚制度化REIT框架,以提高泛波罗的海资本市场的流动性 [1] - 他还参与制定了国有企业融资指南和将私人资本引入廉租房的框架 [1] - 他持有CFA和ESG投资证书,曾在芝加哥交易所实习,并积极参与支持泛波罗的海资本市场发展的"思想领导力"活动 [1] 分组1 - 公司从事金融管理业务,帮助企业制定财务策略和执行融资 [1] - 公司致力于在拉脱维亚制度化REIT框架,以提高当地资本市场流动性 [1] - 公司参与制定国有企业融资指南和将私人资本引入廉租房的框架 [1] 分组2 - 分析师持有CFA和ESG投资证书,具有丰富的从业经验 [1] - 分析师曾在芝加哥交易所实习 [1] - 分析师积极参与支持泛波罗的海资本市场发展的"思想领导力"活动 [1]